If an emmetropic ÂÌñ»»ÆÞ˜high riskÂÌñ»»ÆÞ™ patient has presented with a positive family history of myopia these outcomes will be assessed at 6ÂÌñ»»ÆÞ“12 month visits even if they are not undergoing myopia control.
Based on the findings at the first visit a discussion will be had with the patient/parents on the most appropriate choice of myopia control. At present the options available include MiSight daily lenses and orthokeratology. Depending on which option is chosen the patient will be fitted with the contact lenses at a second visit. Any patient undergoing myopia control will be monitored every 6ÂÌñ»»ÆÞ“12 months to determine the efficacy of the treatment.